Vimarsana
Biggest News Aggregation in the World

Proceedings Before News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Proceedings Before. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Proceedings Before Today - Breaking & Trending Today

Initiatives to Increase Communication Between the USPTO and the FDA Concerning Pharmaceutical Patent Applications | Dechert LLP - Vimarsana News

Initiatives to Increase Communication Between the USPTO and the FDA Concerning Pharmaceutical Patent Applications | Dechert LLP

President Biden, in July 2021, issued an Executive Order (“E.O.”) observing that “too often, patent and other laws have been misused to inhibit or delay — for years and even decades —...

UPSTO Continues Discussion Of Pharmaceutical Patents - Patent - Vimarsana News

UPSTO Continues Discussion Of Pharmaceutical Patents - Patent

The USPTO will be hosting a "public listening session" on January 19, 2023, focusing on USPTO-FDA collaboration initiatives proposed pursuant to President Biden's Executive Order...

Source: mondaq.com
UPSTO Continues Discussion of Pharmaceutical Patents | Foley & Lardner LLP - Vimarsana News

UPSTO Continues Discussion of Pharmaceutical Patents | Foley & Lardner LLP

The USPTO will be hosting a “public listening session” on January 19, 2023, focusing on USPTO-FDA collaboration initiatives proposed pursuant to President Biden's Executive Order on...

USPTO To Hold Pharma Patent Public Discussion Session - Vimarsana News

USPTO To Hold Pharma Patent Public Discussion Session

USPTO will host public listening session focusing on USPTO-FDA collaboration initiatives based on President Biden's Executive Order on Promoting Competition in the American Economy to promote greater access to medicines for American families.

Duties of Disclosure and Reasonable Inquiry Before the USPTO May Include Communications with the FDA and Other Government Agencies | Wilson Sonsini Goodrich & Rosati - Vimarsana News

Duties of Disclosure and Reasonable Inquiry Before the USPTO May Include Communications with the FDA and Other Government Agencies | Wilson Sonsini Goodrich & Rosati

Spurred by President Biden's call for action to increase drug competition and a 2021 letter addressed to the U.S. Patent and Trademark Office (USPTO) by Senators Leahy and Tillis...